Compugen Ltd.
General ticker "CGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $149.1M (TTM average)
Compugen Ltd. follows the US Stock Market performance with the rate: 22.6%.
Estimated limits based on current volatility of 2.1%: low 1.52$, high 1.58$
Factors to consider:
- Total employees count: 2271 as of 2002
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.99$, 2.17$]
- 2025-12-31 to 2026-12-31 estimated range: [0.79$, 1.79$]
Financial Metrics affecting the CGEN estimates:
- Positive: with PPE of -9.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 35.85 > 13.24
- Positive: 41.86 < Shareholder equity ratio, % of 47.75 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0.02 <= 0.79
- Positive: Inventory ratio change, % of -0.69 <= 0
Short-term CGEN quotes
Long-term CGEN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $7.50MM | $33.46MM | $27.86MM |
| Operating Expenses | $42.87MM | $46.45MM | $42.76MM |
| Operating Income | $-35.37MM | $-12.99MM | $-14.89MM |
| Non-Operating Income | $1.74MM | $3.21MM | $5.18MM |
| Interest Expense | $0.03MM | $0.03MM | $0.03MM |
| R&D Expense | $30.65MM | $34.47MM | $24.81MM |
| Income(Loss) | $-33.64MM | $-9.78MM | $-9.71MM |
| Taxes | $0.06MM | $8.97MM | $4.52MM |
| Profit(Loss)* | $-33.69MM | $-18.75MM | $-14.23MM |
| Stockholders Equity | $77.68MM | $65.56MM | $54.91MM |
| Assets | $94.18MM | $121.33MM | $115.00MM |
| Operating Cash Flow | $-33.92MM | $-35.89MM | $49.60MM |
| Capital expenditure | $0.49MM | $0.17MM | $0.12MM |
| Investing Cash Flow | $37.06MM | $35.51MM | $-46.25MM |
| Financing Cash Flow | $0.35MM | $3.08MM | $0.55MM |
| Earnings Per Share** | $-0.39 | $-0.21 | $-0.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.